Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 12,500 | |||
50 mg | 在庫あり | ¥ 14,000 | |||
100 mg | 在庫あり | ¥ 19,000 | |||
200 mg | 在庫あり | ¥ 27,000 | |||
500 mg | 在庫あり | ¥ 45,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant. |
In vitro | Mutated EGFR inhibitor acts as egfr modulators useful for treating cancer. |
別名 | Osimertinib analog |
分子量 | 445.56 |
分子式 | C25H31N7O |
CAS No. | 1421372-66-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.5 mg/mL (16.83 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mutated EGFR-IN-1 1421372-66-8 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR Mutated EGFR IN 1 Epidermal growth factor receptor inhibit ErbB-1 Osimertinib Inhibitor Osimertinib analog HER1 Mutated EGFRIN1 inhibitor